Digital Health (DHAC) Amends Backstop for VSee and iDoc Deal
by Marlena Haddad on 2023-04-12 at 7:34am

Digital Health (NASDAQ:DHAC) announced in an 8-K this morning that it has amended its previously announced backstop agreement in connection to its business combination with telehealth software firm VSee and digital healthcare provider iDoc.

On January 18, the company entered into a backstop agreement with its sponsor to purchase up to $2 million of shares of Series A Preferred Stock and accompanying PIPE warrants that remain unpurchased by the investors.

Digital Health amended this backstop agreement yesterday to increase the financing from $2 million to up to an additional $7 million, to clarify that its sponsor and/or its designees may purchase the backstop commitment and to include a form of a lock-up agreement.

As part of the amendment, the aggregate number of shares of Series A Preferred Stock issuable will not be able to exceed 15,000. Additionally, the form of the PIPE warrant was amended so that Digital Health can redeem the warrants for cash or securities upon a change of control of the company. Certain closing conditions for the PIPE financing were also revised.

As a refresher, DHAC entered into an amended and restated securities purchase agreement on October 6, 2022, with certain accredited investors to have the participation right in subsequent offerings of the company’s equity securities. The PIPE investors agreed to purchase convertible preferred stock of the company designated as Series A Convertible Preferred Stock and warrants exercisable for shares of DHAC common stock for proceeds of at least $8M.  Prior to the closing of the business combination, DHAC intended to offer the PIPE investors the right to purchase up to an additional $2M of shares of its Series A Preferred Stock, or the additional PIPE shares, and accompanying warrants.

Back in August 2022, DHAC entered into a PIPE Securities Purchase Agreement with certain institutional and accredited investors for promissory notes convertible into shares of its common stock, and warrants exercisable for shares of its common stock for proceeds of at least $10M.

The SPAC did not originally include a PIPE at its deal announcement in June 2022, but brought in $115 million into the transaction from its trust, which was later reduced to just $7.05 million after seeing 93.96% redemptions in an October 2022 meeting. 

The deal had already featured a lock-up agreement for the company, at 50% six months after the close and 50% after 12 months after the close, and for the sponsor, at 6 months from the closing, but the parties decided to also include a PIPE Lock-Up Agreement through the securities purchase agreement in August.

California-based VSee provides a no code and low code SaaS platform to help physicians set up telehealth applications and Houston-based iDoc has a set of neurological telehealth tools to treat patients suffering from strokes or other brain injuries.

 

Digital Health (DHAC) Amends Backstop for VSee and iDoc Deal
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved